TOWA PHARMACEUTICAL CO.,LTD. Logo

TOWA PHARMACEUTICAL CO.,LTD.

4553 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
門真市新橋町2番11号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

TOWA PHARMACEUTICAL CO., LTD. is a prominent Japanese pharmaceutical company dedicated to the development, manufacturing, and marketing of innovative medical products. Established with a commitment to improving healthcare, TOWA specializes in a diverse range of therapeutic areas, including generic pharmaceuticals and unique proprietary drugs. With a strong emphasis on research and development, TOWA is focused on delivering high-quality, accessible medications to meet the needs of patients and healthcare providers. The company leverages advanced technology and robust quality control measures to ensure the efficacy and safety of its products. TOWA is positioned as a key player in the pharmaceutical industry, contributing to the advancement of healthcare solutions both in Japan and globally.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for TOWA PHARMACEUTICAL CO.,LTD.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-27 08:01
Regulatory News Service
臨時報告書
Japanese 24.0 KB
2025-06-24 05:01
Regulatory News Service
内部統制報告書-第69期(2024/04/01-2025/03/31)
Japanese 23.6 KB
2025-06-24 05:00
Annual Report
有価証券報告書-第69期(2024/04/01-2025/03/31)
Japanese 1.4 MB
2025-06-24 05:00
Regulatory News Service
確認書
Japanese 8.1 KB
2024-11-13 01:01
Regulatory News Service
確認書
Japanese 8.0 KB
2024-11-13 01:00
Interim Report
半期報告書-第69期(2024/04/01-2025/03/31)
Japanese 207.6 KB
2024-07-10 09:04
Regulatory News Service
確認書
Japanese 8.1 KB
2024-07-10 09:00
Regulatory News Service
訂正有価証券報告書-第68期(2023/04/01-2024/03/31)
Japanese 849.4 KB
2024-06-27 05:54
Regulatory News Service
臨時報告書
Japanese 24.9 KB
2024-06-26 02:02
Regulatory News Service
内部統制報告書-第68期(2023/04/01-2024/03/31)
Japanese 21.7 KB
2024-06-26 02:01
Regulatory News Service
確認書
Japanese 8.1 KB
2024-06-26 02:01
Annual Report
有価証券報告書-第68期(2023/04/01-2024/03/31)
Japanese 1.4 MB
2024-02-14 01:01
Regulatory News Service
確認書
Japanese 8.0 KB
2024-02-14 01:00
Quarterly Report
四半期報告書-第68期第3四半期(2023/10/01-2023/12/31)
Japanese 169.1 KB
2023-11-14 01:00
Regulatory News Service
確認書
Japanese 8.0 KB

Automate Your Workflow. Get a real-time feed of all TOWA PHARMACEUTICAL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for TOWA PHARMACEUTICAL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Antibiotice S.A. Logo
Manufactures FDA-approved generic drugs, sterile injectables, and APIs for global markets.
Romania ATB
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
Arctic Bioscience Logo
Develops pharma & nutra ingredients from marine lipids for autoimmune & wellness applications.
Norway ABS
ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway AZT
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands 1AE
Japan 4886
Astellas Pharma Inc. Logo Japan 4503
AstraZeneca PLC Logo
A global biopharma firm developing medicines for oncology, rare diseases, and biopharmaceuticals.
United Kingdom AZN
Bachem Holding AG Logo
A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.
Switzerland BANB